Reduced reaction frequencies with repeated inactivated or live-attenuated influenza vaccination

被引:12
作者
Ohmit, Suzanne E. [1 ]
Gross, Jonathan [1 ]
Victor, John C. [1 ,2 ]
Monto, Arnold S. [1 ]
机构
[1] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA
[2] Program Appropriate Technol Hlth, Seattle, WA USA
关键词
Influenza vaccines; Adverse reactions; Inactivated influenza vaccine; Live-attenuated influenza vaccine; RANDOMIZED CONTROLLED-TRIAL; PLACEBO-CONTROLLED TRIAL; EVENT REPORTING SYSTEM; ADVERSE REACTIONS; WORKING ADULTS; UNITED-STATES; VACCINES; CHILDREN; PREVENTION; SAFETY;
D O I
10.1016/j.vaccine.2008.11.100
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Data collected as part of a multi-year trial examining the efficacies of inactivated and live-attenuated influenza vaccines were used to evaluate the reported occurrence of post-vaccination reactions. Two cohorts were defined: (1) individuals who received the same vaccine over two consecutive years, and (2) individuals who first enrolled in year 2 of the Study and received vaccine only in that year. For both vaccines there were significantly fewer reactions reported in year 2 in those subjects who were vaccinated both years, Declines were demonstrated when comparing year 1 and 2 reaction frequencies in subjects vaccinated both years, and differences were seen when comparing year 2 reaction frequencies in subjects vaccinated both years with those first vaccinated in year 2. Reaction reporting peaked on post-vaccination days 0 and 1 following receipt of the inactivated vaccine, and on day 2 following receipt of the live-attenuated vaccine. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1050 / 1054
页数:5
相关论文
共 22 条
  • [1] COMPARATIVE TRIAL OF INFLUENZA VACCINES .2. ADVERSE REACTIONS IN CHILDREN AND ADULTS
    BARRY, DW
    MAYNER, RE
    HOCHSTEIN, HD
    DUNLAP, RC
    RASTOGI, SC
    HANNAH, JE
    BLACKBURN, RJ
    SULLIVAN, JL
    GERETY, RJ
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1976, 104 (01) : 47 - 59
  • [2] Safety, efficacy, and effectiveness of live, attenuated, cold-adapted influenza vaccine in an indicated population aged 5-49 years
    Belshe, RB
    Nichol, KL
    Black, SB
    Shinefield, H
    Cordova, J
    Walker, R
    Hessel, C
    Cho, I
    Mendelman, PM
    [J]. CLINICAL INFECTIOUS DISEASES, 2004, 39 (07) : 920 - 927
  • [3] Safety, efficacy and effectiveness of cold-adapted, live, attenuated, trivalent, intranasal influenza vaccine in adults and children
    Belshe, RB
    Gruber, WC
    [J]. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES, 2001, 356 (1416) : 1947 - 1951
  • [4] Risk of anaphylaxis after vaccination of children and adolescents
    Bohlke, K
    Davis, RL
    Marcy, SM
    Braun, MM
    DeStefano, F
    Black, SB
    Mullooly, JP
    Thompson, RS
    [J]. PEDIATRICS, 2003, 112 (04) : 815 - 820
  • [5] *CDCP, 2003, MMWR-MORBID MORTAL W, V53, P1012
  • [6] Safety of influenza vaccinations administered in nontraditional settings
    D'Heilly, Sarah J.
    Blade, Mary Ann
    Nichol, Kristin L.
    [J]. VACCINE, 2006, 24 (18) : 4024 - 4027
  • [7] A RANDOMIZED CONTROLLED TRIAL OF COLD-ADAPTED AND INACTIVATED VACCINES FOR THE PREVENTION OF INFLUENZA A DISEASE
    EDWARDS, KM
    DUPONT, WD
    WESTRICH, MK
    PLUMMER, WD
    PALMER, PS
    WRIGHT, PF
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (01) : 68 - 76
  • [8] PATIENT ACCEPTANCE OF INFLUENZA VACCINATION
    FIEBACH, NH
    VISCOLI, CM
    [J]. AMERICAN JOURNAL OF MEDICINE, 1991, 91 (04) : 393 - 400
  • [9] Fiore Anthony E., 2007, Morbidity and Mortality Weekly Report, V56, P1
  • [10] ADVERSE REACTIONS TO INFLUENZA VACCINE IN ELDERLY PEOPLE - RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL
    GOVAERT, TME
    DINANT, GJ
    ARETZ, K
    MASUREL, N
    SPRENGER, MJW
    KNOTTNERUS, JA
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1993, 307 (6910): : 988 - 990